Abbott India Ltd

Abbott India Ltd

₹ 28,592 0.47%
27 Feb 3:31 p.m.
About

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.[1] It was established in 1944.[2]

Key Points

Abbott Group
The company is a part of Abbott Laboratories. The group has a presence in 160+ countries across the globe with a legacy of 130+ years.[1] [2]

  • Market Cap 60,757 Cr.
  • Current Price 28,592
  • High / Low 29,639 / 19,906
  • Stock P/E 53.0
  • Book Value 1,463
  • Dividend Yield 0.63 %
  • ROCE 41.1 %
  • ROE 31.6 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.6%
  • Company has been maintaining a healthy dividend payout of 76.8%

Cons

  • Stock is trading at 19.6 times its book value
  • The company has delivered a poor sales growth of 10.2% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
1,095 1,096 1,218 1,222 1,224 1,255 1,304 1,379 1,322 1,343 1,479 1,494 1,437
854 890 953 962 955 961 1,034 1,036 1,010 1,063 1,124 1,113 1,049
Operating Profit 242 206 265 260 269 294 270 343 312 280 355 381 388
OPM % 22% 19% 22% 21% 22% 23% 21% 25% 24% 21% 24% 25% 27%
15 16 19 18 19 21 27 34 44 50 56 56 56
Interest 4 5 5 5 4 5 4 4 4 4 3 3 3
Depreciation 15 15 16 16 17 17 17 17 18 17 17 18 18
Profit before tax 238 202 264 257 267 292 275 355 335 308 390 415 422
Tax % 26% 24% 26% 25% 25% 28% 25% 25% 26% 25% 26% 25% 26%
177 152 196 192 199 211 206 266 247 231 290 313 311
EPS in Rs 83.36 71.75 92.13 90.51 93.74 99.49 96.77 124.95 116.16 108.91 136.59 147.27 146.35
Raw PDF

Profit & Loss

Figures in Rs. Crores

Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
1,490 1,653 2,276 2,289 2,614 2,903 3,298 3,679 4,093 4,310 4,913 5,349 5,753
1,315 1,451 2,009 1,977 2,250 2,505 2,774 3,074 3,336 3,388 3,832 4,143 4,350
Operating Profit 176 202 267 312 365 398 525 605 757 922 1,082 1,206 1,404
OPM % 12% 12% 12% 14% 14% 14% 16% 16% 18% 21% 22% 23% 24%
19 33 49 48 50 57 117 113 114 81 83 154 217
Interest 0 0 0 0 3 2 4 2 9 18 19 16 14
Depreciation 15 19 22 15 14 16 16 17 60 58 66 70 70
Profit before tax 180 215 295 344 398 436 621 699 803 926 1,080 1,274 1,536
Tax % 33% 33% 33% 34% 36% 37% 35% 36% 26% 25% 26% 25%
120 145 198 229 255 277 401 450 593 691 799 949 1,146
EPS in Rs 56.66 68.10 93.39 107.75 120.12 130.19 188.82 211.93 279.04 325.04 375.87 446.80 539.12
Dividend Payout % 30% 25% 25% 29% 29% 31% 29% 31% 90% 85% 73% 73%
Compounded Sales Growth
10 Years: 12%
5 Years: 10%
3 Years: 9%
TTM: 9%
Compounded Profit Growth
10 Years: 21%
5 Years: 19%
3 Years: 17%
TTM: 23%
Stock Price CAGR
10 Years: 32%
5 Years: 31%
3 Years: 26%
1 Year: 38%
Return on Equity
10 Years: 27%
5 Years: 28%
3 Years: 30%
Last Year: 32%

Balance Sheet

Figures in Rs. Crores

Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 21 21 21 21 21 21 21 21 21 21 21 21 21
Reserves 523 626 767 916 1,174 1,366 1,672 1,987 2,410 2,581 2,799 3,167 3,088
0 0 0 0 0 0 0 0 175 153 152 113 92
253 260 351 436 421 679 723 932 940 1,086 1,253 1,254 1,315
Total Liabilities 797 907 1,139 1,374 1,616 2,066 2,416 2,941 3,547 3,840 4,224 4,556 4,516
80 109 98 96 108 110 81 105 270 251 271 237 225
CWIP 0 1 1 4 3 6 2 1 2 1 1 4 12
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
717 798 1,040 1,274 1,505 1,950 2,333 2,835 3,275 3,589 3,952 4,315 4,278
Total Assets 797 907 1,139 1,374 1,616 2,066 2,416 2,941 3,547 3,840 4,224 4,556 4,516

Cash Flows

Figures in Rs. Crores

Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
24 101 155 215 249 307 153 499 626 727 948 893
56 -59 -144 -187 -77 -155 -215 -257 -401 -72 -396 -148
-42 -42 -42 -58 -80 -90 -102 -143 -217 -582 -637 -639
Net Cash Flow 38 1 -31 -30 91 62 -165 99 8 73 -86 107

Ratios

Figures in Rs. Crores

Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 32 31 18 21 20 22 29 27 28 21 21 22
Inventory Days 108 99 101 107 91 107 112 106 83 110 94 80
Days Payable 51 38 38 54 56 101 92 116 104 116 122 109
Cash Conversion Cycle 89 92 80 74 54 28 49 17 8 14 -6 -8
Working Capital Days 46 49 36 30 32 21 63 22 14 7 -4 -5
ROCE % 42% 34% 39% 40% 38% 34% 41% 37% 35% 35% 38% 41%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99%
1.01% 0.25% 0.24% 0.22% 0.22% 0.20% 0.20% 0.20% 0.19% 0.19% 0.19% 0.18%
5.53% 6.74% 6.88% 6.76% 7.52% 7.95% 7.85% 8.38% 8.61% 8.77% 8.83% 8.73%
18.47% 18.03% 17.89% 18.04% 17.27% 16.86% 16.95% 16.42% 16.20% 16.05% 16.01% 16.09%
No. of Shareholders 84,47875,54073,41783,23690,56782,11383,52674,91572,08669,58268,88572,252

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents